Abstract:Even prior to the onset of the prodromal stages of Alzheimer's disease (AD), a constellation of sleep disturbances are apparent. A series of epidemiological studies indicate that multiple forms of these sleep disturbances are associated with increased risk for developing mild cognitive impairment (MCI) and AD, even triggering disease onset at an earlier age. Through the combination of causal manipulation studies in humans and rodents, as well as targeted examination of sleep disturbance with respect to AD biom… Show more
“…Indeed, the existence of a possible relationship between sleep disruption and signs of AD pathology before the beginning of cognitive deterioration would imply that specific sleep alterations may represent early biomarkers of the neurodegenerative process. At present, many findings go in this direction [10,114,142].…”
Section: A Mechanistic Link Between Nrem Sleep Alterations and Ad Promentioning
confidence: 93%
“…The importance of SWA and sleep spindles for learning and plasticity is broadly accepted [108,113]. A growing number of studies points to the existence of a relationship between alterations of NREM sleep oscillations and AD progression [114]. In this vein, one line of evidence highlights signs of disrupted NREM oscillations in healthy aging and their further and specific deterioration in AD.…”
Section: Electrophysiological Alterations Of Nrem Sleep With the Progmentioning
confidence: 99%
“…AD pathology is associated with a further, progressive, and regionally-specific disruption of NREM sleep electrophysiology compared to healthy aging [114]. Beyond the consolidated evidence of SWS reduction and fragmentation in AD/MCI [124][125][126][127][128][129] associated with the severity of memory impairment [125,130], AD is characterized by greater alterations of NREM EEG hallmarks compared to normal aging, even at an early stage of the neurodegenerative disease.…”
Section: Electrophysiological Alterations Of Nrem Sleep With the Progmentioning
confidence: 99%
“…According to Mander [114], the available findings on the sleep-AD relation suggest that the pathological components of AD (i.e., Aβ, tau, neurodegeneration) are specifically associated with alterations in local and global expressions of sleep depending on the cerebral area affected. Such sleep alterations evolve with the progression of the neurodegenerative process and may be related to memory impairment.…”
Section: A Mechanistic Link Between Nrem Sleep Alterations and Ad Promentioning
The multifactorial nature of Alzheimer’s disease (AD) has led scientific researchers to focus on the modifiable and treatable risk factors of AD. Sleep fits into this context, given the bidirectional relationship with AD confirmed by several studies over the last years. Sleep disorders appear at an early stage of AD and continue throughout the entire course of the pathology. Specifically, sleep abnormalities, such as more fragmented sleep, increase in time of awakenings, worsening of sleep quality and primary sleep disorders raise with the severity and progression of AD. Intervening on sleep, therefore, means acting both with prevention strategies in the pre-clinical phase and with treatments during the course of the disease. This review explores sleep disturbances in the different stages of AD, starting from the pre-clinical stage. Particular attention is given to the empirical evidence investigating obstructive sleep apnea (OSA) disorder and the mechanisms overlapping and sharing with AD. Next, we discuss sleep-based intervention strategies in the healthy elderly population, mild cognitive impairment (MCI) and AD patients. We mention interventions related to behavioral strategies, combination therapies, and bright light therapy, leaving extensive space for new and raising evidence on continuous positive air pressure (CPAP) treatment effectiveness. Finally, we clarify the role of NREM sleep across the AD trajectory and consider the most recent studies based on the promising results of NREM sleep enhancement, which use innovative experimental designs and techniques.
“…Indeed, the existence of a possible relationship between sleep disruption and signs of AD pathology before the beginning of cognitive deterioration would imply that specific sleep alterations may represent early biomarkers of the neurodegenerative process. At present, many findings go in this direction [10,114,142].…”
Section: A Mechanistic Link Between Nrem Sleep Alterations and Ad Promentioning
confidence: 93%
“…The importance of SWA and sleep spindles for learning and plasticity is broadly accepted [108,113]. A growing number of studies points to the existence of a relationship between alterations of NREM sleep oscillations and AD progression [114]. In this vein, one line of evidence highlights signs of disrupted NREM oscillations in healthy aging and their further and specific deterioration in AD.…”
Section: Electrophysiological Alterations Of Nrem Sleep With the Progmentioning
confidence: 99%
“…AD pathology is associated with a further, progressive, and regionally-specific disruption of NREM sleep electrophysiology compared to healthy aging [114]. Beyond the consolidated evidence of SWS reduction and fragmentation in AD/MCI [124][125][126][127][128][129] associated with the severity of memory impairment [125,130], AD is characterized by greater alterations of NREM EEG hallmarks compared to normal aging, even at an early stage of the neurodegenerative disease.…”
Section: Electrophysiological Alterations Of Nrem Sleep With the Progmentioning
confidence: 99%
“…According to Mander [114], the available findings on the sleep-AD relation suggest that the pathological components of AD (i.e., Aβ, tau, neurodegeneration) are specifically associated with alterations in local and global expressions of sleep depending on the cerebral area affected. Such sleep alterations evolve with the progression of the neurodegenerative process and may be related to memory impairment.…”
Section: A Mechanistic Link Between Nrem Sleep Alterations and Ad Promentioning
The multifactorial nature of Alzheimer’s disease (AD) has led scientific researchers to focus on the modifiable and treatable risk factors of AD. Sleep fits into this context, given the bidirectional relationship with AD confirmed by several studies over the last years. Sleep disorders appear at an early stage of AD and continue throughout the entire course of the pathology. Specifically, sleep abnormalities, such as more fragmented sleep, increase in time of awakenings, worsening of sleep quality and primary sleep disorders raise with the severity and progression of AD. Intervening on sleep, therefore, means acting both with prevention strategies in the pre-clinical phase and with treatments during the course of the disease. This review explores sleep disturbances in the different stages of AD, starting from the pre-clinical stage. Particular attention is given to the empirical evidence investigating obstructive sleep apnea (OSA) disorder and the mechanisms overlapping and sharing with AD. Next, we discuss sleep-based intervention strategies in the healthy elderly population, mild cognitive impairment (MCI) and AD patients. We mention interventions related to behavioral strategies, combination therapies, and bright light therapy, leaving extensive space for new and raising evidence on continuous positive air pressure (CPAP) treatment effectiveness. Finally, we clarify the role of NREM sleep across the AD trajectory and consider the most recent studies based on the promising results of NREM sleep enhancement, which use innovative experimental designs and techniques.
“…Cortex ISF flow path dimensions are very small, and the dimensional sensitivity to shear, e.g., in a capillary, is highly nonlinear. An added dimension in this consideration is that cortex flow rates are reported to increase during sleep [ 37, 38 ]. The case has been made by the author [ 10 ] for shear-induced aggregation producing Aβ-containing cerebral amyloid angioplasty (CAA) deposits in and around the arteries surrounding and entering the cortex.…”
Section: Flow Stresses Within the Cerebral Cortexmentioning
Amyloid-β (Aβ) and tau oligomers have been identified as neurotoxic agents responsible for causing Alzheimer’s disease (AD). Clinical trials using Aβ and tau as targets have failed, giving rise to calls for new research approaches to combat AD. This paper provides such an approach. Most basic AD research has involved quiescent Aβ and tau solutions. However, studies involving laminar and extensional flow of proteins have demonstrated that mechanical agitation of proteins induces or accelerates protein aggregation. Recent MRI brain studies have revealed high energy, chaotic motion of cerebrospinal fluid (CSF) in lower brain and brainstem regions. These and studies showing CSF flow within the brain have shown that there are two energetic hot spots. These are within the third and fourth brain ventricles and in the neighborhood of the circle of Willis blood vessel region. These two regions are also the same locations as those of the earliest Aβ and tau AD pathology. In this paper, it is proposed that cardiac systolic pulse waves that emanate from the major brain arteries in the lower brain and brainstem regions and whose pulse waves drive CSF flows within the brain are responsible for initiating AD and possibly other amyloid diseases. It is further proposed that the triggering of these diseases comes about because of the strengthening of systolic pulses due to major artery hardening that generates intense CSF extensional flow stress. Such stress provides the activation energy needed to induce conformational changes of both Aβ and tau within the lower brain and brainstem region, producing unique neurotoxic oligomer molecule conformations that induce AD.
Age-related neurodegeneration characteristic of late-onset Alzheimer's disease (LOAD) begins in middle age, well before symptoms. Translational models to identify modifiable risk factors are needed to understand etiology and identify therapeutic targets. Here, we outline the evidence supporting the vervet monkey (Chlorocebus aethiops sabaeus) as a model of aging-related AD-like neuropathology and associated phenotypes including cognitive function, physical function, glucose handling, intestinal physiology, and CSF, blood, and neuroimaging biomarkers. This review provides the most comprehensive multisystem description of aging in vervets to date. This review synthesizes a large body of evidence that suggests that aging vervets exhibit a coordinated suite of traits consistent with early AD and provide a powerful, naturally occurring model for LOAD. Notably, relationships are identified between AD-like neuropathology and modifiable risk factors. Gaps in knowledge and key limitations are provided to shape future studies to illuminate mechanisms underlying divergent neurocognitive aging trajectories and to develop interventions that increase resilience to aging-associated chronic disease, particularly, LOAD.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.